Diffuse large cell lymphomas exhibit frequent deletions in 9p21–22 and 9q31–34 regions

Genes, Chromosomes and Cancer

Volumn 12, Issue 1, 1995, Pages 32-36

  Chaganti, Seeta R ^a   Louie, Diane C ^a   Chaganti, R S K ^a   Gaidano, Gianluca ^b   Dalla‐Favera, Riccardo ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 9; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MAPPING; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 9; GENE DELETION; HUMAN; LYMPHOMA, LARGE-CELL, DIFFUSE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028876874     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.2870120106     Document Type: Article

References (23)

1. Cytogenetic studies on Burkitt's lymphoma cell lines
2. Preliminary mapping of deleted region of chromosome 9 in bladder cancer
3. Homozygous deletions within 9p21–22 identify a small critical region of chromosomal loss in human malignant mesotheliomas
4. Homozygous deletion of the alpha‐ and beta 1‐interferon genes in human leukemia and derived cell lines
5. Deletions of interferon genes in acute lymphoblastic leukemia
6. Homozygous deletions within chromosome band 9p21 in melanoma
7. Deletions involving two distinct regions of 6q in B‐cell non‐Hodgkin lymphoma
8. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group
9. A cell cycle regulator potentially involved in genesis of many tumor types
10. P53 mutations are associated with histologic transformation of follicular lymphoma
11. Frequent loss of chromosome 9 in human primary non‐small cell lung cancer
12. Allelotype of head and neck squamous cell carcinoma
13. Cytogenetic analysis of 434 consecutively ascertained specimens of non‐Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment
14. Chromosomal aberrations in non‐Hodgkin's lymphoma
15. Clusters of chromosome 9 aberrations are associated with clinico‐pathologic subsets of non‐Hodgkin's lymphoma
16. 6q deletions define distinct clinico‐pathologic subsets of non‐Hodgkin's lymphoma
17. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas
18. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers
19. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors
20. Report of the committee on the genetic constitution of chromosome 9. Chromosome Coordinating Meeting (1992);
21. Chromosomal analysis of bladder cancer. III. Nonrandom alterations
22. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer
23. Alterations of a zinc‐finger encoding gene, bcl‐6, in diffuse large cell lymphoma